Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Assessment of myocardial viability with [15O]water PET: A validation study in experimental myocardial infarction (2021)
- Journal of Nuclear Cardiology
- EKG-tapaus (2021)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
- Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4-5 (2021)
- Nephron Physiology
- Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study (2021)
- Annals of Medicine
- Intracranial aneurysm is predicted by abdominal aortic calcification index: A retrospective case-control study (2021)
- Atherosclerosis
- Minor troponin T elevation and mortality in patients with atrial fibrillation presenting to the emergency department (2021)
- European Journal of Clinical Investigation
- Red blood cell transfusion induces abnormal HIF-1 alpha response to cytokine storm after adult cardiac surgery (2021)
- Scientific Reports
- Adverse events and survival with postpericardiotomy syndrome after surgical aortic valve replacement (2020)
- Journal of Thoracic and Cardiovascular Surgery
- Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation (2020)
- JAMA Network Open
- Classification of Atrial Fibrillation and Acute Decompensated Heart Failure Using Smartphone Mechanocardiography: A Multi-label Learning Approach (2020)
- IEEE Sensors Journal
- Full feature selection for estimating KAP radiation dose in coronary angiographies and percutaneous coronary interventions (2020)
- Computers in Biology and Medicine
- Indications and predictors for pacemaker implantation after isolated aortic valve replacement with bioprostheses: the CAREAVR study (2020)
- Interactive Cardiovascular and Thoracic Surgery
- Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease (2020)
- BMC Cardiovascular Disorders
- Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation (2020)
- Circulation
- Painevaijeritutkimus - käytänkö lepo- vai hyperemiamittauksia? (2020)
- Sydänääni: Suomen Kardiologisen Seuran Lehti
- Population trends in aortic valve surgery in Finland between 2001 and 2016 (2020)
- Scandinavian Cardiovascular Journal
- Postpericardiotomy syndrome after cardiac surgery (2020)
- Annals of Medicine
- Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study (2020)
- Clinical Cardiology
- Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis (2020)
- Thrombosis Research
- Sepelvaltimotautipotilaan eteisvärinä - miten valitsen hyytymisenestolääkityksen? (2020)
- Sydänääni: Suomen Kardiologisen Seuran Lehti



